These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25557081)

  • 21. Arthritis possibly induced and exacerbated by a tumour necrosis factor antagonist in a patient with psoriasis vulgaris.
    Takahashi T; Asano Y; Shibata S; Nakamura K; Nakao M; Shida R; Mitsui A; Araki M; Watanabe R; Fujita H; Tada Y; Sato S
    Br J Dermatol; 2015; 172(5):1458-60. PubMed ID: 25565011
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ustekinumab-induced eosinophilic pneumonia during the course of ustekinumab therapy for plaque psoriasis].
    Amy de la Bretèque M; Appere-De Vecchi C; Zeboulon C; Zaien I; Sigal ML; Mahé E
    Ann Dermatol Venereol; 2015 Mar; 142(3):193-6. PubMed ID: 25624139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of ustekinumab in severe psoriasis with chronic hepatitis B.
    Raymundo AR; Facin AP; Silva de Castro CC; Faria AR
    Indian J Dermatol Venereol Leprol; 2016; 82(3):326-8. PubMed ID: 27088944
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of ustekinumab in five psoriatic patients with hepatitis B virus infection.
    Piaserico S; Conti A; Coati I; Galdo G; Bernabucci V; Zanca A; Drabeni M; Masutti F; Musumeci ML; Alberti A; Russo FP
    G Ital Dermatol Venereol; 2019 Jun; 154(3):376-377. PubMed ID: 28712266
    [No Abstract]   [Full Text] [Related]  

  • 25. Cutaneous protothecosis in a patient on ustekinumab for psoriasis.
    Jenkinson H; Thelin L; McAndrew R; Jones KM; Talbott LB; Diven D
    Int J Dermatol; 2018 Oct; 57(10):1246-1248. PubMed ID: 29603193
    [No Abstract]   [Full Text] [Related]  

  • 26. Intracranial hypertension and memory loss in a patient treated with ustekinumab.
    Abdelnabi M; Short J; Khoromi S; Ehrlich A
    Australas J Dermatol; 2015 May; 56(2):146-7. PubMed ID: 25900637
    [No Abstract]   [Full Text] [Related]  

  • 27. Exacerbation of atopic dermatitis symptoms by ustekinumab in psoriatic patients with elevated serum immunoglobulin E levels: Report of two cases.
    Ishiuji Y; Umezawa Y; Asahina A; Fukuta H; Aizawa N; Yanaba K; Nakagawa H
    J Dermatol; 2018 Jun; 45(6):732-734. PubMed ID: 29569296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible paradoxical occurrence of inflammatory arthritis in patients with psoriasis treated with biologics: findings in the Biobadaderm cohort.
    Ruiz-Genao D; Perez-Zafrilla B; Lopez-Estebaranz JL; Belinchón-Romero I; Carrascosa JM; Ferrán M; Vanaclocha F; Herrera-Ceballos E; García-Doval I;
    Br J Dermatol; 2017 Mar; 176(3):797-799. PubMed ID: 27120993
    [No Abstract]   [Full Text] [Related]  

  • 29. Case of recurrent severe cellulitis and cutaneous candidiasis during psoriasis treatment with ustekinumab.
    Miyachi H; Nakamura Y; Wakabayashi S; Iwasawa MT; Oikawa A; Watanabe A; Matsue H
    J Dermatol; 2017 Aug; 44(8):e206-e207. PubMed ID: 28432713
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period.
    Megna M; Napolitano M; Balato N; Monfrecola G; Villani A; Ayala F; Balato A
    Clin Exp Dermatol; 2016 Jul; 41(5):564-6. PubMed ID: 27028505
    [No Abstract]   [Full Text] [Related]  

  • 31. Liver Injury in Psoriasis Patients Receiving Ustekinumab: A Retrospective Study of 44 Patients Treated in the Clinical Practice Setting.
    Llamas-Velasco M; Concha-Garzón MJ; García-Diez A; Daudén E
    Actas Dermosifiliogr; 2015; 106(6):470-6. PubMed ID: 25912374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy.
    Fujita Y; Shinkuma S; Nomura T; Shimizu H
    Eur J Dermatol; 2016 Apr; 26(2):187-8. PubMed ID: 26643260
    [No Abstract]   [Full Text] [Related]  

  • 33. A Case of Severe Transaminase Elevation Following a Single Ustekinumab Dose with Remission After Drug Withdrawal.
    Lovero R; Losurdo G; Mastromauro M; Castellaneta NM; Mongelli A; Gentile A; Di Leo A; Principi M
    Curr Drug Saf; 2018; 13(3):221-223. PubMed ID: 30027852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple Clustered Dermatofibromas Following Ustekinumab Treatment for
    Ruiz-Villaverde R; Díaz-Martinez MA; Sánchez-Cano D
    Sultan Qaboos Univ Med J; 2017 Aug; 17(3):e375-e377. PubMed ID: 29062570
    [No Abstract]   [Full Text] [Related]  

  • 35. [Efficacy and safety of ustekinumab in psoriatic arthritis after anti-TNFα failure in routine practice].
    Michel M; Reguiai Z; Fauconier M; Brochot P; Eschard JP; Salmon JH
    Therapie; 2016 Jun; 71(3):281-6. PubMed ID: 27235651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe dilated cardiomyopathy induced by adalimumab and ustekinumab.
    Membrillo de Novales FJ; Ávila Jiménez A; Merino Meléndez L; Torres León J; López Soberón E; Fe Marqués A; Pérez Mochales JF
    J Clin Rheumatol; 2015 Apr; 21(3):171-3. PubMed ID: 25807103
    [No Abstract]   [Full Text] [Related]  

  • 37. Thrombocytopenia in a psoriatic patient sequentially treated with adalimumab, secukinumab and ustekinumab.
    Nakahara T; Konishi S; Yasukochi Y; Esaki H; Tsuji G; Kido-Nakahara M; Furue M
    J Dermatol; 2019 May; 46(5):e157-e158. PubMed ID: 30353917
    [No Abstract]   [Full Text] [Related]  

  • 38. Varicella zoster virus meningitis under ustekinumab because of plaque psoriasis.
    Stöllberger C; Finsterer J
    J Dermatol; 2017 Jun; 44(6):703-705. PubMed ID: 28150333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrotic syndrome in relation to treatment with ustekinumab.
    Pérez Fernández M; Piteiro Bermejo AB; Peña Esparragoza JK; Blasco Martínez A; Aracil Moreno I; Mancha Ramos J; Moreno Barrio F
    Nefrologia (Engl Ed); 2019; 39(1):100-102. PubMed ID: 30107955
    [No Abstract]   [Full Text] [Related]  

  • 40. Ustekinumab treatment in patients with psoriasis undergoing hemodialysis.
    Umezawa Y; Hayashi M; Kikuchi S; Fukuchi O; Yanaba K; Ito T; Asahina A; Saeki H; Nakagawa H
    J Dermatol; 2015 Jul; 42(7):731-4. PubMed ID: 25959602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.